[go: up one dir, main page]

GB0804687D0 - Humanized antibody - Google Patents

Humanized antibody

Info

Publication number
GB0804687D0
GB0804687D0 GB0804687A GB0804687A GB0804687D0 GB 0804687 D0 GB0804687 D0 GB 0804687D0 GB 0804687 A GB0804687 A GB 0804687A GB 0804687 A GB0804687 A GB 0804687A GB 0804687 D0 GB0804687 D0 GB 0804687D0
Authority
GB
United Kingdom
Prior art keywords
humanized antibody
humanized
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0804687A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest AG
Original Assignee
Biotest AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest AG filed Critical Biotest AG
Priority to GB0804687A priority Critical patent/GB0804687D0/en
Publication of GB0804687D0 publication Critical patent/GB0804687D0/en
Priority to CN2009801173185A priority patent/CN102027018A/en
Priority to AU2009224690A priority patent/AU2009224690B2/en
Priority to KR1020107022912A priority patent/KR20100135808A/en
Priority to JP2010550182A priority patent/JP5604311B2/en
Priority to ES09720958.9T priority patent/ES2610327T3/en
Priority to NZ602518A priority patent/NZ602518A/en
Priority to SG2013034210A priority patent/SG190627A1/en
Priority to RU2010141822/10A priority patent/RU2540018C2/en
Priority to EP09720958.9A priority patent/EP2260057B1/en
Priority to PCT/EP2009/052810 priority patent/WO2009112502A1/en
Priority to MX2010010027A priority patent/MX2010010027A/en
Priority to BRPI0909179-3A priority patent/BRPI0909179A2/en
Priority to CA2717812A priority patent/CA2717812A1/en
Priority to IL207892A priority patent/IL207892A0/en
Priority to US12/880,768 priority patent/US9550831B2/en
Priority to CR11723A priority patent/CR11723A/en
Priority to CO10127116A priority patent/CO6311008A2/en
Priority to JP2014011246A priority patent/JP2014101369A/en
Ceased legal-status Critical Current

Links

GB0804687A 2008-03-13 2008-03-13 Humanized antibody Ceased GB0804687D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB0804687A GB0804687D0 (en) 2008-03-13 2008-03-13 Humanized antibody
CA2717812A CA2717812A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
RU2010141822/10A RU2540018C2 (en) 2008-03-13 2009-03-10 Agent for disease treatment
PCT/EP2009/052810 WO2009112502A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
KR1020107022912A KR20100135808A (en) 2008-03-13 2009-03-10 Disease Remedy
JP2010550182A JP5604311B2 (en) 2008-03-13 2009-03-10 Disease treatment agent
ES09720958.9T ES2610327T3 (en) 2008-03-13 2009-03-10 Dosing regimen of anti-CD4 antibodies for the treatment of autoimmune diseases
NZ602518A NZ602518A (en) 2008-03-13 2009-03-10 Agent for treating disease
SG2013034210A SG190627A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
CN2009801173185A CN102027018A (en) 2008-03-13 2009-03-10 Agent for treating disease
EP09720958.9A EP2260057B1 (en) 2008-03-13 2009-03-10 Anti-CD4 antibody dosage regimen for treating autoimmune disease
AU2009224690A AU2009224690B2 (en) 2008-03-13 2009-03-10 Agent for treating disease
MX2010010027A MX2010010027A (en) 2008-03-13 2009-03-10 Agent for treating disease.
BRPI0909179-3A BRPI0909179A2 (en) 2008-03-13 2009-03-10 Pharmaceutical composition and method of treatment of an autoimmune disease.
IL207892A IL207892A0 (en) 2008-03-13 2010-08-31 Agent for treating disease
US12/880,768 US9550831B2 (en) 2008-03-13 2010-09-13 Method for treating psoriasis
CR11723A CR11723A (en) 2008-03-13 2010-10-11 AGENT TO TREAT DISEASE
CO10127116A CO6311008A2 (en) 2008-03-13 2010-10-13 PHARMACEUTICAL COMPOSITION UNDERSTANDING AN AGENT THAT ACTIVATES REGULATORY T-CELLS CD4 + CD25 +
JP2014011246A JP2014101369A (en) 2008-03-13 2014-01-24 Agent for treating disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0804687A GB0804687D0 (en) 2008-03-13 2008-03-13 Humanized antibody

Publications (1)

Publication Number Publication Date
GB0804687D0 true GB0804687D0 (en) 2008-04-16

Family

ID=39328068

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0804687A Ceased GB0804687D0 (en) 2008-03-13 2008-03-13 Humanized antibody

Country Status (1)

Country Link
GB (1) GB0804687D0 (en)

Similar Documents

Publication Publication Date Title
ZA201005348B (en) Humanized anti-c5ar antibodies
SG10201601279SA (en) Monoclonal Antibody STRO-4
EP2331579A4 (en) Monoclonal antibodies
IL204835A0 (en) Humanized antibody
EP2241578A4 (en) Anti-cldn6 antibody
AP3371A (en) Anti-IGF antibodies
EP2349331A4 (en) Humanized anti-il-6 antibodies
ZA201102119B (en) Improved antibody libraies
IL217919A0 (en) Humanized anti-cdcp1 antibodies
GB0821100D0 (en) Antibodies
HK1168871A1 (en) Monoclonal antibodies
IL207581A0 (en) Anti-tyrp1 antibodies
EP2274332A4 (en) Anti-tnf antibody
ZA201007976B (en) Anti-pirb antibodies
GB0818356D0 (en) Antibodies
ZA201004770B (en) Improved humanized anti-human x9-integrin antibody
GB0911770D0 (en) Antibody
GB0804684D0 (en) Humanized antibody
GB0804687D0 (en) Humanized antibody
GB0804686D0 (en) Humanized antibody
GB0706964D0 (en) Humanized antibody
GB0706963D0 (en) Humanized antibody
GB0706965D0 (en) Humanized antibody
TWI348915B (en) Anti-vegf monoclonal antibody
GB0817621D0 (en) Antibody

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)